An observational study in Covid19 and SARS-CoV Infection, sponsored by Evidation Health. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-01-11.
Sponsored by Evidation Health · Observational
Prospective, observational, exploratory study exploring the relationship between passively-collected data from wearable activity devices and SARS-CoV-2 infection
6,687 studies on the registry are indexed under Infections; 807 are open to participants now.
This study's enrollment of 847 is above the median of 240 across 2,136 observational studies indexed under Infections.
Browse Infections studies →Evidation Health is the lead sponsor of 14 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Adult participants (ages 18+) who reside in the contiguous United States and are at elevated risk of contracting COVID-19.
Exclusion Criteria:
Individuals who are randomly assigned to receive the Garmin vívosmart® 4
Individuals who are randomly assigned to receive the Empatica E4
Development of database containing physiological, behavioral data in combination with SARS-CoV-2 infection
To develop a database of physiological and behavioral data via wearable devices and self-reported questionnaires (e.g.,symptoms) combined with laboratory confirmation of SARS- CoV-2 infection.
Time frame: Through study completion, an average of 7 months
Correlation between SARS-CoV-2 infection and collected wearable data and self-reported data
Physiological and behavioral data from wearable devices (Garmin vivosmart 4, Empatica E4) , patient self-reported data questionnaires (includes but is not limited to demographics, symptoms, medical history, lifestyle, comorbidities, and Medical care utilization), and laboratory diagnostic confirmation of SARS-CoV-2 infection.
Time frame: Through study completion, an average of 7 months
Lift of the analytical models as expressed as the ratio of COVID-19+ recall (COVID-19+ cases detected by model as a percentage of total positive cases)/Healthy false positives (healthy cases detected by the model as being COVID-19+).
Lift is a measure of model performance and will be evaluated at multiple timepoints along the infection time-course (for example, 1 day prior to illness onset, onset, day 3, etc.)
Time frame: Through study completion, an average of 7 months
Plan to share: No
This study is completed, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Evidation Health